2CTech Inc. has initiated a clinical trial program for quantum dots, a nanoparticle technology treatment candidate for retinal diseases, according to a press release.
The study will test the safety and efficacy of quantum dots – semiconductor crystalline structures that absorb light and generate a dipole electrical field, stimulating the retina cells – in retinitis pigmentosa patients.
“We are more than gratified to have reached this point in the development of this unique and high-potential therapeutic approach for what are otherwise debilitating retinal diseases and conditions,”
Uncategorized